Journals / Eurasian Journal of Medicine / 2022 / Cilt: 54 - Sayı: 2

Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus

Pages
197–201
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that our study will guide future studies conducted in this field.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the present study, the relationship between a poor prognosis and adropin levels in diabetic patients with coronavirus disease 2019 was investigated by measuring serum adropin levels and levels of D-dimer, C-reactive protein, and ferritin, which are considered prognostic factors for coronavirus disease 2019.
📊
Key Findings & Data:Results: The participants’ serum adropin levels differed between the groups (P = .0007).
💡
Conclusion & Impact:We think that our study will guide future studies conducted in this field.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In the present study, the relationship between a poor prognosis and adropin levels in diabetic patients with coronavirus disease 2019 was investigated by measuring serum adropin levels and levels of D-dimer, C-reactive protein, and ferritin, which are considered prognostic factors for coronavirus disease 2019. Materials and Methods: Hundred volunteer participants treated in the Erzurum Regional Training and Research Hospital were included in this study. Serum adropin levels were measured by enzyme-linked immunosorbent assay. The relationship between serum adropin level and C-reactive protein, ferritin, and D-dimer levels was analyzed by correlation analysis. Results: The participants’ serum adropin levels differed between the groups (P = .0007). The control group had the highest adropin levels among groups. The lowest adropin levels were in the COVID + diabetes mellitus group. Adropin levels of diabetes mellitus, COVID, and diabetes mellitus + COVID groups were significantly decreased when compared to the control (P < .05). There was a significant negative correlation between adropin and C-reactive protein, D-dimer, and ferritin. Conclusion: Adropin can be used as an auxiliary biomarker, a prognostic factor in the early management of coronavirus disease 2019 patients with diabetes mellitus. We think that our study will guide future studies conducted in this field.

🔖

Cite This Article

TÖR, İ. H., AYDIN, P., UZUNÇAKMAK, S. K., BİLEN, A., ÖZDEN, A. (2022). Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus. Eurasian Journal of Medicine, Cilt: 54 - Sayı: 2, 197–201. https://ajindex.com/articles/508790

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Meo SA, Alhowikan AM, Al-Khlaiwi T, et al. Novel coronavirus 2019-Ncov: prevalence, biological and clinical characteristics comparison with SARS-Cov and MERS-Cov. Eur Rev Med Pharmacol Sci. 2020
  2. 24(4):2012-2019. [CrossRef] 2. Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020
  3. 368(March):m1036. [CrossRef] 3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  4. 395(10223):497- 506. [CrossRef] 4. Harcourt J, Tamin A, Lu X, et al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis. 2020
  5. 26(6):1266-1273. [CrossRef] 5. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020
  6. 180(7):934-943. [CrossRef] 6. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID- 19 in China. Clin Res Cardiol. 2020
  7. 109(5):531- 538. [CrossRef] 7. Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-Cov-2. J Endocrinol Invest. 2020
  8. 43(6):867-869. [CrossRef] 8. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020
  9. 323(21):2195-2198. [CrossRef] 9. Piva S, Filippini M, Turla F, et al. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection in Brescia, Italy. J Crit Care. 2020
  10. [CrossRef] 10. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020
  11. 323(11):1061-1069. [CrossRef] 11. Fang C, Huang Y, Guo H, et al. Mechanism of higher risk for COVID-19 in diabetes: a mask to lift. Endocrine. 2020
  12. 69(3):477-480. [CrossRef] 12. Codo AC, et al. Elevated glucose levels favor SARS-Cov-2 infection and monocyte response Through a HIF-1 α/gly colys is-de pende nt axis. Cell Metab. 2020
  13. 32(3):437-446.E5. 13. Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008
  14. 8(6):468-481. [CrossRef] 14. Jasaszwili M, Billert M, Strowski MZ, Nowak KW, Sk